(Q44052727)

29 November 2017

title

Novel growth factors involved in the pathogenesis of proliferative vitreoretinopathy (English)

1 reference

29 November 2017

Hinton DR

1

1 reference

29 November 2017

He S

2

1 reference

29 November 2017

Jin ML

3

1 reference

29 November 2017

Barron E

4

1 reference

29 November 2017

Ryan SJ

5

1 reference

29 November 2017

publication date

1 July 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

16

1 reference

29 November 2017

issue

4

1 reference

29 November 2017

page(s)

422-428

1 reference

The pathophysiology of proliferative vitreoretinopathy in its management

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Clinical risk factors for proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Post-traumatic proliferative vitreoretinopathy. The epidemiologic profile, onset, risk factors, and visual outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Natural history of fibrocellular epiretinal membranes: a quantitative, autoradiographic, and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Molecular therapy in ocular wound healing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Mitogen-activated protein kinase activation mediates PDGF-directed migration of RPE cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Photoreceptor-specific expression of platelet-derived growth factor-B results in traction retinal detachment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Transforming growth factor beta 2 is the predominant isoform in the neural retina, retinal pigment epithelium-choroid and vitreous of the monkey eye

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Thrombospondins as matricellular modulators of cell function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Latency, activation, and binding proteins of TGF-beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Hepatocyte growth factor/scatter factor in the eye

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Retinal pigment epithelial cells secrete and respond to hepatocyte growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Hepatocyte growth factor levels in the vitreous of patients with proliferative vitreoretinopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Hepatocyte growth factor/scatter factor decreases the expression of occludin and transendothelial resistance (TER) and increases paracellular permeability in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Contribution of Bcl-2, but not Bcl-xL and Bax, to antiapoptotic actions of hepatocyte growth factor in hypoxia-conditioned human endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Hepatocyte growth factor enhances MMP activity in human endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Hepatocyte growth factor attenuates collagen accumulation in a murine model of pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Transforming growth factor beta2 inhibition of hepatocyte growth factor-induced endothelial proliferation and migration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Characterization of cell-associated and soluble forms of connective tissue growth factor (CTGF) produced by fibroblast cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Characterization of 16- to 20-kilodalton (kDa) connective tissue growth factors (CTGFs) and demonstration of proteolytic activity for 38-kDa CTGF in pig uterine luminal flushings.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Overexpression of connective tissue growth factor gene induces apoptosis in human aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Connective tissue growth factor induces apoptosis via caspase 3 in cultured human aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Expression of connective tissue growth factor in human renal fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Connective tissue growth factor: a potential stimulus for glomerulosclerosis and tubulointerstitial fibrosis in progressive renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Human connective tissue growth factor is expressed in advanced atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6700190

7 January 2021

Identifiers

DOI

10.1038/SJ.EYE.6700190

1 reference

29 November 2017

1 reference